Edgen Stock·Sep 18 2025, 21:04戻る
戻る
Royalty Pharma Reports Robust Q2 2025 Performance Amid Strategic Expansion
Edgen Stock·Sep 18 2025, 21:04
[1] Royalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 Receipts (https://finance.yahoo.com/news/royalty-pharma ...)[2] Royalty Pharma Reports Second Quarter 2025 Results (https://vertexaisearch.cloud.google.com/groun ...)[3] Royalty Pharma Completes the Acquisition of Its External Manager - GlobeNewswire (https://vertexaisearch.cloud.google.com/groun ...)